We talk about why he reframes exit as a strategy rather than a transaction, the 90-day cycles he uses to close the gap between a company’s floor and its premium valuation, and the 75% of founders who regret selling within a year — usually because they planned for the business but not for what comes next. We also get into how valuation really works when the market, not a third-party report, sets the price, the wave of boomer owners with up to 80% of their net worth locked inside their companies, and his concept of the integrated CEO: aligning business, financial, and personal life so that judgment and energy don’t quietly erode the value of everything else.

We dig into Krista’s argument that venture, at its core, has a contract problem more than a funding problem - that the asset class works as a power-law game, but the absence of any clean “we tried, here’s how we part ways” infrastructure is what leaves so many otherwise-good businesses stranded. We get into why she thinks today’s setup - post-COVID overfunding, AI disruption, and an unusually concentrated venture market — adds up to a generational buying opportunity for sponsors willing to clean up cap tables.

We also cover where senior lenders fit in (roughly half of Edited’s deal flow comes through private credit funds, often as a forcing function in workouts), why M&A is the most underused growth lever in early-stage tech, how Krista thinks about hosting costs, headcount, and the question of what the business actually needs to do today, and how AI-native companies that didn’t make their Series A are already starting to show up in her pipeline.

We start with Charles’s foundation at Union Bank, where learning to underwrite real businesses created an early framework for thinking about risk. From there, we move into his time with MUFG in Singapore, where he navigated cross-border lending, large multinational clients, and the realities of operating inside a global bank.

The conversation then shifts to Silicon Valley Bank, where Charles transitioned from the deal side into the credit seat—offering a candid perspective on what actually changes when you’re the one making the decision.

We spend time unpacking how credit gets structured in practice, how institutional incentives shape outcomes, and why collaboration between deal teams and credit is often the difference between getting a deal done—or not.

We close with one of the more practical takeaways from the episode: Charles’s “User Guide,” a simple but effective framework for how he approaches communication, expectations, and decision-making as a credit officer.

If you’re building a career in banking—or just want a clearer view into how credit decisions actually get made—this is a worthwhile listen.

Drawing on more than 16 years inside the venture banking ecosystem, Marshall unpacks why venture debt is ultimately a relationship business—and why the choice of lending partner often matters more than headline pricing or structure. The discussion weaves through real-world case studies from Marshall’s career, including Twitch/Justin.tv, Airbnb, and Clearco, highlighting both successful outcomes and hard-earned lessons when incentives, timing, or expectations fall out of alignment.

The conversation also explores how lenders evaluate risk, the often-misunderstood role of warrants and so-called “non-dilutive” capital, and what founders and CFOs should realistically expect from the debt process—from preparation and documentation to credit committee dynamics. Marshall and Derek reflect on the culture and institutional knowledge that shaped venture lending during the SVB era, as well as how today’s more fragmented lending landscape has changed borrower decision-making.

This episode is particularly relevant for founders, CFOs, board members, and lenders seeking a candid, experience-driven view of venture debt—not as a theoretical product, but as a long-term relationship that can either support growth or amplify risk depending on how it is used.

We dive into Avenue’s underwriting in life sciences, what makes an attractive med device or biopharma opportunity, and why management experience is often the most critical factor. Jake also reflects on today’s tight equity markets, the role of private credit as “the most popular kid in school,” and how AI tools are changing portfolio management.